Guggenheim reiterated their sell rating on shares of Rite Aid (NYSE:RAD) in a report released on Thursday, Briefing.com Automated Import reports.
RAD has been the topic of a number of other reports. Zacks Investment Research raised shares of Rite Aid from a hold rating to a buy rating and set a $10.00 price objective on the stock in a research report on Thursday, April 11th. Loop Capital lowered their price objective on shares of Rite Aid from $27.00 to $20.00 and set a hold rating on the stock in a research report on Thursday, December 20th. Two equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. The company currently has a consensus rating of Hold and an average target price of $38.33.
Shares of RAD opened at $0.49 on Thursday. Rite Aid has a 52 week low of $0.43 and a 52 week high of $2.12. The company has a quick ratio of 0.91, a current ratio of 1.68 and a debt-to-equity ratio of 2.93.
Hedge funds have recently bought and sold shares of the business. Capstone Financial Advisors Inc. bought a new stake in Rite Aid in the third quarter worth approximately $32,000. Lombard Odier Asset Management USA Corp bought a new stake in Rite Aid in the third quarter worth approximately $32,000. Marshall Wace LLP bought a new stake in Rite Aid in the third quarter worth approximately $47,000. Wedbush Securities Inc. grew its position in Rite Aid by 111.9% in the fourth quarter. Wedbush Securities Inc. now owns 37,875 shares of the company’s stock worth $27,000 after acquiring an additional 20,000 shares in the last quarter. Finally, Nwam LLC bought a new stake in Rite Aid in the fourth quarter worth approximately $27,000. 45.76% of the stock is owned by institutional investors.
About Rite Aid
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
See Also: Mutual Funds
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.